Speaker - David Shaywitz

 David  Shaywitz  Thumbnail


Dr. Shaywitz is a graduate of Harvard College (summa cum laude), and received his MD from the Health Sciences and Technology program at Harvard Medical School and MIT, and his PhD from the Department of Biology at MIT. He trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard.

He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group's Healthcare and Corporate Development practices, where he focused on strategy and organizational design. He is currently Director of Strategic and Commercial Planning at Theravance, a publicly-held drug development company in South San Francisco.

Dr. Shaywitz is a co-founder (with Dennis Ausiello) of the Harvard PASTEUR program, a translational research initiative at Harvard Medical School ( He is also a founding advisor of Sage, a non-profit medical research initiative (founded by Eric Schadt and Stephen Friend) emphasizing networks and open innovation (

For the last fifteen years, Dr. Shaywitz has contributed commentaries about medicine, science, innovation, and business to a number of popular publications, including The New York Times, The Washington Post, The Wall Street Journal, and The Financial Times. He currently is a regular contributor to

Dr. Shaywitz is an Adjunct Scholar at the American Enterprise Institute.

1 Program

Opening the Sources of Drug Discovery

10.23.11 | 01:39:23 min | 0 comments